SARS-CoV-2 spike conformation determines plasma neutralizing activity elicited by a wide panel of human vaccines.
Journal
Science immunology
ISSN: 2470-9468
Titre abrégé: Sci Immunol
Pays: United States
ID NLM: 101688624
Informations de publication
Date de publication:
23 12 2022
23 12 2022
Historique:
pubmed:
11
11
2022
medline:
28
12
2022
entrez:
10
11
2022
Statut:
ppublish
Résumé
Numerous safe and effective coronavirus disease 2019 vaccines have been developed worldwide that use various delivery technologies and engineering strategies. We show here that vaccines containing prefusion-stabilizing S mutations elicit antibody responses in humans with enhanced recognition of S and the S
Identifiants
pubmed: 36356052
doi: 10.1126/sciimmunol.adf1421
pmc: PMC9765460
doi:
Substances chimiques
Antibodies, Viral
0
Antibodies, Neutralizing
0
COVID-19 Vaccines
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
eadf1421Subventions
Organisme : NIAID NIH HHS
ID : R25 AI147376
Pays : United States
Organisme : NIAID NIH HHS
ID : DP1 AI158186
Pays : United States
Organisme : NIAID NIH HHS
ID : 75N93022C00036
Pays : United States
Organisme : NIGMS NIH HHS
ID : R01 GM120553
Pays : United States
Organisme : NIAID NIH HHS
ID : U01 AI151698
Pays : United States
Organisme : NIAID NIH HHS
ID : U19 AI142742
Pays : United States
Commentaires et corrections
Type : UpdateOf